Cameron Hogarth, Ph.D.

Postdoctoral Research Associate
University of Liverpool, United Kingdom

Poster(s):

• (W1230-08-50) Preclinical Development of a Long-Acting Injectable Formulation of Rifapentine from High Throughput Screening through to a GLP-Toxicology Study
  Wednesday, November 12, 2025

  12:30 PM - 1:30 PM CT

• (M1430-09-59) Control of Particle Size, Distribution and Modality of a Rifapentine Solid Drug Nanoparticle Formulation through Modified Formulation Approaches
  Monday, November 10, 2025

  2:30 PM - 3:30 PM CT

• (M1430-09-61) Preclinical Development of Long-Acting Injectable Formulations of Glecaprevir and Pibrentasvir for Curative Treatment of Hepatitis C in Low- and Middle-Income Countries
  Monday, November 10, 2025

  2:30 PM - 3:30 PM CT